Shanghai Kaibao Pharmaceutical CO.,Ltd (SHE:300039)
China · Delayed Price · Currency is CNY 5.73
0.00 (0.00%)
May 20, 2026, 1:45 PM CST
Shanghai Kaibao Pharmaceutical CO.,Ltd Company Description
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern Chinese medicines primarily in China.
Its primary products include Tanreqing injection for the treatment of pneumonia, acute and chronic bronchitis, and upper respiratory tract infection; Tanreqing capsules that clears heat and detoxifies and removes phlegm; tiopronin for injection, which improves liver function of various acute and chronic hepatitis; Tiopronin enteric-coated tablets for adjuvant treatment of chronic hepatitis; and Xiongdan dropping pills that clears heat, calms liver, and improves eyesight.
The company was founded in 2000 and is based in Shanghai, China.
Shanghai Kaibao Pharmaceutical CO.,Ltd
| Country | China |
| Founded | 2000 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,225 |
| CEO | Yingbin Zhou |
Contact Details
Address: No. 88 Chengpu Road Shanghai China | |
| Phone | 86 21 3757 2030 |
Stock Details
| Ticker Symbol | 300039 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000JZ3 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yingbin Zhou | GM and Director |
| Jianzhong Liu | Deputy GM and Non-Independent Director |
| Liwang Ren | Board Secretary and Non-Independent Director |
| Ying Jun Zhu | Deputy General Manager |
| You Long Chen | Financial Director |
| Ya Ru Li | Accounting Supervisor |